Bespoke Services, Absolute Peace Of Mind
The Pharmacy @ NCIS serves all outpatients at the cancer centre infusion centres as well as patients who have been warded in the hospital. They include both adult and paediatric haematology-oncology patients, blood and marrow transplant patients, benign haematology patients, uro-oncology patients, gynaecologic oncology patients and also patients from rheumatology, renal services who require immunosuppressant therapy.
It provides specialised oncology drug compounding services for all anti-cancer therapies in the NCIS as well as the filling and dispensing of oral anti-cancer drugs and related supportive therapy at the outpatient cancer centre pharmacy. Besides specialised drug compounding and distribution services, oncology pharmacists are involved in the provision of specialised clinical pharmacy services such as patient counseling of new anti-cancer therapies and the provision of drug information to patients and members of our healthcare team. To stay current with the latest oncology advances and pharmacy practices, our staff are constantly upgrading and deepening their skill sets through various training and post-graduate educational programmes.
The Division of Oncology Pharmacy is very much involved in the conduct and management of clinical trials, both investigator-initiated and pharmaceutical industry-initiated. The oncology pharmacists also conduct clinical oncology pharmacy based research here.
It runs the safe handling of anti-cancer drugs and aseptic dispensing certificate course as well as aseptic dispensing validation tests for both pharmacists and pharmacy technicians from the National University Hospital and external organisations. It is also the training site for both the National Pharmacy Residency PGY1 and PGY2 oncology residents as well as the NUH Pharmacy PGY1 residents. The Pharmacy @ NCIS frequently hosts local and foreign pharmacy undergraduates, pre-registration pharmacists, pharmacists, pharmacy technicians, nurses and healthcare administrators to share about its specialised oncology services.
Back to Top